SEC Info - Kraig Biocraft Laboratories, Inc. - ‘S-1/A’ on 6/6/23

SEC Info℠

Home

My Interests

Help

Please Sign In

Kraig Biocraft Laboratories, Inc. – ‘S-1/A’ on 6/6/23 – ‘EX-101.CAL’

On: Tuesday, 6/6/23, at 4:31pm ET · Accession #: 1493152-23-20299 · File #: 333-238883

Previous ‘S-1’: ‘S-1/A’ on 5/9/23 · Next: ‘S-1/A’ on 9/1/23 · Latest: ‘S-1/A’ on 11/22/23 · 19 References:

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/06/23  Kraig Biocraft Laboratories, Inc. S-1/A                 66:13M                                    M2 Compliance LLC/FA

Pre-Effective Amendment to Registration Statement (General Form) — Form S-1 — SA’33

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1/A       Pre-Effective Amendment to Registration Statement   HTML   3.89M 
                (General Form)                                                   
 2: EX-23.1     Consent of Expert or Counsel                        HTML     18K 
 8: R1          Cover                                               HTML     53K 
 9: R2          Condensed Consolidated Balance Sheets               HTML    132K 
10: R3          Condensed Consolidated Balance Sheets               HTML     53K 
                (Parenthetical)                                                  
11: R4          Condensed Consolidated Statements of Operations     HTML     91K 
12: R5          Condensed Consolidated Statement of Changes in      HTML     99K 
                Stockholders Deficit                                             
13: R6          Condensed Consolidated Statement of Changes in      HTML     30K 
                Stockholders Deficit (Parenthetical)                             
14: R7          Condensed Consolidated Statements of Cash Flows     HTML    123K 
15: R8          Summary of Significant Accounting Policies and      HTML    195K 
                Organization                                                     
16: R9          Going Concern                                       HTML     27K 
17: R10         Equipment                                           HTML     50K 
18: R11         Right to Use Assets and Lease Liability             HTML    111K 
19: R12         Note Payable - Related Party                        HTML     51K 
20: R13         Loan Payable                                        HTML     38K 
21: R14         Convertible Notes                                   HTML    232K 
22: R15         Stockholders? Deficit                               HTML    548K 
23: R16         Commitments and Contingencies                       HTML    123K 
24: R17         Related Party Transactions                          HTML     85K 
25: R18         Subsequent Events                                   HTML     24K 
26: R19         Summary of Significant Accounting Policies and      HTML    235K 
                Organization (Policies)                                          
27: R20         Summary of Significant Accounting Policies and      HTML    111K 
                Organization (Tables)                                            
28: R21         Equipment (Tables)                                  HTML     46K 
29: R22         Right to Use Assets and Lease Liability (Tables)    HTML     78K 
30: R23         Convertible Notes (Tables)                          HTML     90K 
31: R24         Stockholders? Deficit (Tables)                      HTML    357K 
32: R25         Related Party Transactions (Tables)                 HTML     36K 
33: R26         Schedule of Antidilutive Securities of Earnings     HTML     37K 
                Per Share (Details)                                              
34: R27         Schedule of Antidilutive Securities of Earnings     HTML     34K 
                Per Share (Details) (Parenthetical)                              
35: R28         Schedule of Fair Value of Financial Instruments     HTML     42K 
                (Details)                                                        
36: R29         Schedule of Gold in Bullion (Details)               HTML     44K 
37: R30         Summary of Significant Accounting Policies and      HTML     54K 
                Organization (Details Narrative)                                 
38: R31         Going Concern (Details Narrative)                   HTML     29K 
39: R32         Schedule of Property and Equipment (Details)        HTML     47K 
40: R33         Equipment (Details Narrative)                       HTML     21K 
41: R34         Schedule of Operating Leases (Details)              HTML     36K 
42: R35         Schedule of Minimum Lease Payments (Details)        HTML     39K 
43: R36         Right to Use Assets and Lease Liability (Details    HTML     79K 
                Narrative)                                                       
44: R37         Note Payable - Related Party (Details Narrative)    HTML     73K 
45: R38         Loan Payable (Details Narrative)                    HTML     64K 
46: R39         Schedule of Fair Value Warrants (Details)           HTML     47K 
47: R40         Summary of Convertible Debt (Details)               HTML     49K 
48: R41         Convertible Notes (Details Narrative)               HTML    292K 
49: R42         Schedule of Option Assumption (Details)             HTML     42K 
50: R43         Schedule of Warrants Activity (Details)             HTML     74K 
51: R44         Schedule of Warrants Outstanding (Details)          HTML     63K 
52: R45         Schedule of Options Activity (Details)              HTML    134K 
53: R46         Schedule of Options Outstanding (Details)           HTML     27K 
54: R47         Stockholders? Deficit (Details Narrative)           HTML    442K 
55: R48         Commitments and Contingencies (Details Narrative)   HTML    266K 
56: R49         Schedule of Accounts Payable and Accrued Expenses   HTML     30K 
                Related Party (Details)                                          
57: R50         Related Party Transactions (Details Narrative)      HTML    146K 
58: R51         Schedule of Deferred Tax Assets and Liabilities     HTML     30K 
                (Details)                                                        
59: R52         Schedule of Deferred Tax Assets and Liabilities     HTML     21K 
                (Details) (Parenthetical)                                        
60: R53         Schedule of Components Deferred Income Taxes        HTML     31K 
                (Details)                                                        
61: R54         Subsequent Events (Details Narrative)               HTML     28K 
64: XML         IDEA XML File -- Filing Summary                      XML    121K 
62: XML         XBRL Instance -- forms-1a_htm                        XML   3.70M 
63: EXCEL       IDEA Workbook of Financial Report Info              XLSX    232K 
 4: EX-101.CAL  XBRL Calculations -- kblb-20230331_cal               XML    150K 
 5: EX-101.DEF  XBRL Definitions -- kblb-20230331_def                XML    759K 
 6: EX-101.LAB  XBRL Labels -- kblb-20230331_lab                     XML   1.26M 
 7: EX-101.PRE  XBRL Presentations -- kblb-20230331_pre              XML    993K 
 3: EX-101.SCH  XBRL Schema -- kblb-20230331                         XSD    179K 
65: JSON        XBRL Instance as JSON Data -- MetaLinks              438±   639K 
66: ZIP         XBRL Zipped Folder -- 0001493152-23-020299-xbrl      Zip    617K

‘EX-101.CAL’ — XBRL Calculations — kblb-20230331_cal

This Exhibit is an XBRL File.

<?xml version="1.0" standalone="no" encoding="windows-1252"?>

<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">

<link:roleRef roleURI="http://kraiglabs.com/role/Cover" xlink:href="kblb-20230331.xsd#Cover" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/BalanceSheets" xlink:href="kblb-20230331.xsd#BalanceSheets" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/BalanceSheetsParenthetical" xlink:href="kblb-20230331.xsd#BalanceSheetsParenthetical" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/StatementsOfOperations" xlink:href="kblb-20230331.xsd#StatementsOfOperations" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/StatementOfChangesInStockholdersDeficit" xlink:href="kblb-20230331.xsd#StatementOfChangesInStockholdersDeficit" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/StatementOfChangesInStockholdersDeficitParenthetical" xlink:href="kblb-20230331.xsd#StatementOfChangesInStockholdersDeficitParenthetical" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/StatementsOfCashFlows" xlink:href="kblb-20230331.xsd#StatementsOfCashFlows" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/SummaryOfSignificantAccountingPoliciesAndOrganization" xlink:href="kblb-20230331.xsd#SummaryOfSignificantAccountingPoliciesAndOrganization" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/GoingConcern" xlink:href="kblb-20230331.xsd#GoingConcern" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/Equipment" xlink:href="kblb-20230331.xsd#Equipment" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/RightToUseAssetsAndLeaseLiability" xlink:href="kblb-20230331.xsd#RightToUseAssetsAndLeaseLiability" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/NotePayableRelatedParty" xlink:href="kblb-20230331.xsd#NotePayableRelatedParty" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/LoanPayable" xlink:href="kblb-20230331.xsd#LoanPayable" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/ConvertibleNotes" xlink:href="kblb-20230331.xsd#ConvertibleNotes" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/StockholdersDeficit" xlink:href="kblb-20230331.xsd#StockholdersDeficit" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/CommitmentsAndContingencies" xlink:href="kblb-20230331.xsd#CommitmentsAndContingencies" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/RelatedPartyTransactions" xlink:href="kblb-20230331.xsd#RelatedPartyTransactions" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/SubsequentEvents" xlink:href="kblb-20230331.xsd#SubsequentEvents" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/SummaryOfSignificantAccountingPoliciesAndOrganizationPolicies" xlink:href="kblb-20230331.xsd#SummaryOfSignificantAccountingPoliciesAndOrganizationPolicies" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/SummaryOfSignificantAccountingPoliciesAndOrganizationTables" xlink:href="kblb-20230331.xsd#SummaryOfSignificantAccountingPoliciesAndOrganizationTables" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/EquipmentTables" xlink:href="kblb-20230331.xsd#EquipmentTables" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/RightToUseAssetsAndLeaseLiabilityTables" xlink:href="kblb-20230331.xsd#RightToUseAssetsAndLeaseLiabilityTables" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/ConvertibleNotesTables" xlink:href="kblb-20230331.xsd#ConvertibleNotesTables" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/StockholdersDeficitTables" xlink:href="kblb-20230331.xsd#StockholdersDeficitTables" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/RelatedPartyTransactionsTables" xlink:href="kblb-20230331.xsd#RelatedPartyTransactionsTables" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/ScheduleOfAntidilutiveSecuritiesOfEarningsPerShareDetails" xlink:href="kblb-20230331.xsd#ScheduleOfAntidilutiveSecuritiesOfEarningsPerShareDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/ScheduleOfAntidilutiveSecuritiesOfEarningsPerShareDetailsParenthetical" xlink:href="kblb-20230331.xsd#ScheduleOfAntidilutiveSecuritiesOfEarningsPerShareDetailsParenthetical" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/ScheduleOfFairValueOfFinancialInstrumentsDetails" xlink:href="kblb-20230331.xsd#ScheduleOfFairValueOfFinancialInstrumentsDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/ScheduleOfGoldInBullionDetails" xlink:href="kblb-20230331.xsd#ScheduleOfGoldInBullionDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/SummaryOfSignificantAccountingPoliciesAndOrganizationDetailsNarrative" xlink:href="kblb-20230331.xsd#SummaryOfSignificantAccountingPoliciesAndOrganizationDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/GoingConcernDetailsNarrative" xlink:href="kblb-20230331.xsd#GoingConcernDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="kblb-20230331.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/EquipmentDetailsNarrative" xlink:href="kblb-20230331.xsd#EquipmentDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/ScheduleOfOperatingLeasesDetails" xlink:href="kblb-20230331.xsd#ScheduleOfOperatingLeasesDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/ScheduleOfMinimumLeasePaymentsDetails" xlink:href="kblb-20230331.xsd#ScheduleOfMinimumLeasePaymentsDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/RightToUseAssetsAndLeaseLiabilityDetailsNarrative" xlink:href="kblb-20230331.xsd#RightToUseAssetsAndLeaseLiabilityDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/NotePayableRelatedPartyDetailsNarrative" xlink:href="kblb-20230331.xsd#NotePayableRelatedPartyDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/LoanPayableDetailsNarrative" xlink:href="kblb-20230331.xsd#LoanPayableDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/ScheduleOfFairValueWarrantsDetails" xlink:href="kblb-20230331.xsd#ScheduleOfFairValueWarrantsDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/SummaryOfConvertibleDebtDetails" xlink:href="kblb-20230331.xsd#SummaryOfConvertibleDebtDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/ConvertibleNotesDetailsNarrative" xlink:href="kblb-20230331.xsd#ConvertibleNotesDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/ScheduleOfOptionAssumptionDetails" xlink:href="kblb-20230331.xsd#ScheduleOfOptionAssumptionDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/ScheduleOfWarrantsActivityDetails" xlink:href="kblb-20230331.xsd#ScheduleOfWarrantsActivityDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/ScheduleOfWarrantsOutstandingDetails" xlink:href="kblb-20230331.xsd#ScheduleOfWarrantsOutstandingDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/ScheduleOfOptionsActivityDetails" xlink:href="kblb-20230331.xsd#ScheduleOfOptionsActivityDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/ScheduleOfOptionsOutstandingDetails" xlink:href="kblb-20230331.xsd#ScheduleOfOptionsOutstandingDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/StockholdersDeficitDetailsNarrative" xlink:href="kblb-20230331.xsd#StockholdersDeficitDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="kblb-20230331.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/ScheduleOfAccountsPayableAndAccruedExpensesRelatedPartyDetails" xlink:href="kblb-20230331.xsd#ScheduleOfAccountsPayableAndAccruedExpensesRelatedPartyDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="kblb-20230331.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="kblb-20230331.xsd#ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetailsParenthetical" xlink:href="kblb-20230331.xsd#ScheduleOfDeferredTaxAssetsAndLiabilitiesDetailsParenthetical" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/ScheduleOfComponentsDeferredIncomeTaxesDetails" xlink:href="kblb-20230331.xsd#ScheduleOfComponentsDeferredIncomeTaxesDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://kraiglabs.com/role/SubsequentEventsDetailsNarrative" xlink:href="kblb-20230331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/Cover" xlink:title="00000001 - Document - Cover"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaapDepositsAssetsCurrent"/>

<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapDepositsAssetsCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentInPhysicalCommodities" xlink:label="loc_us-gaapInvestmentInPhysicalCommodities"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapInvestmentInPhysicalCommodities" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset"/>

<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit"/>

<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapSecurityDeposit" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="loc_us-gaapAccruedRoyaltiesCurrent"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedRoyaltiesCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent"/>

<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent"/>

<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableCurrent" xlink:label="loc_us-gaapLoansPayableCurrent"/>

<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLoansPayableCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable"/>

<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleNotesPayable" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermLoansPayable" xlink:label="loc_us-gaapLongTermLoansPayable"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLongTermLoansPayable" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="kblb-20230331.xsd#KBLB_CommonStockIssuable" xlink:label="loc_KBLBCommonStockIssuable"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_KBLBCommonStockIssuable" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital"/>

<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit"/>

<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1"/>

</link:calculationLink>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations">

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OfficersCompensation" xlink:label="loc_us-gaapOfficersCompensation"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapOfficersCompensation" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="kblb-20230331.xsd#KBLB_RentRelatedParty" xlink:label="loc_KBLBRentRelatedParty"/>

<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_KBLBRentRelatedParty" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense"/>

<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="kblb-20230331.xsd#KBLB_NetChangeInUnrealizedDepreciationOnInvestmentInGoldBullion" xlink:label="loc_KBLBNetChangeInUnrealizedDepreciationOnInvestmentInGoldBullion"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_KBLBNetChangeInUnrealizedDepreciationOnInvestmentInGoldBullion" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="loc_us-gaapInterestExpenseDebtExcludingAmortization"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpenseDebtExcludingAmortization" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaapAmortizationOfFinancingCosts"/>

<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapAmortizationOfFinancingCosts" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOperating" xlink:label="loc_us-gaapInterestIncomeOperating"/>

<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestIncomeOperating" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1"/>

</link:calculationLink>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/StatementOfChangesInStockholdersDeficit" xlink:title="00000005 - Statement - Condensed Consolidated Statement of Changes in Stockholders Deficit"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/StatementOfChangesInStockholdersDeficitParenthetical" xlink:title="00000006 - Statement - Condensed Consolidated Statement of Changes in Stockholders Deficit (Parenthetical)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Condensed Consolidated Statements of Cash Flows">

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="kblb-20230331.xsd#KBLB_NetChangeInUnrealizedGainlossInGoldBullions" xlink:label="loc_KBLBNetChangeInUnrealizedGainlossInGoldBullions"/>

<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_KBLBNetChangeInUnrealizedGainlossInGoldBullions" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims"/>

<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment"/>

<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" weight="-1"/>

<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfFinancingCosts" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="kblb-20230331.xsd#KBLB_ImputedInterestRelatedParty" xlink:label="loc_KBLBImputedInterestRelatedParty"/>

<link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_KBLBImputedInterestRelatedParty" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="kblb-20230331.xsd#KBLB_WarrantsIssuedcancelledToConsultants" xlink:label="loc_KBLBWarrantsIssuedcancelledToConsultants"/>

<link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_KBLBWarrantsIssuedcancelledToConsultants" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories"/>

<link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense"/>

<link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInSecurityDeposits" xlink:label="loc_us-gaapIncreaseDecreaseInSecurityDeposits"/>

<link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInSecurityDeposits" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="kblb-20230331.xsd#KBLB_IncreaseDecreaseInOperatingLeaseRightofuseAssets" xlink:label="loc_KBLBIncreaseDecreaseInOperatingLeaseRightofuseAssets"/>

<link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_KBLBIncreaseDecreaseInOperatingLeaseRightofuseAssets" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInDueToRelatedPartiesCurrent"/>

<link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableTrade"/>

<link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableTrade" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability"/>

<link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_us-gaapPaymentsToAcquireInvestments"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireInvestments" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt"/>

<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfDebt" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises"/>

<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1"/>

</link:calculationLink>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/SummaryOfSignificantAccountingPoliciesAndOrganization" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/GoingConcern" xlink:title="00000009 - Disclosure - GOING CONCERN"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/Equipment" xlink:title="00000010 - Disclosure - EQUIPMENT"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/RightToUseAssetsAndLeaseLiability" xlink:title="00000011 - Disclosure - RIGHT TO USE ASSETS AND LEASE LIABILITY"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/NotePayableRelatedParty" xlink:title="00000012 - Disclosure - NOTE PAYABLE – RELATED PARTY"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/LoanPayable" xlink:title="00000013 - Disclosure - LOAN PAYABLE"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/ConvertibleNotes" xlink:title="00000014 - Disclosure - CONVERTIBLE NOTES"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/StockholdersDeficit" xlink:title="00000015 - Disclosure - STOCKHOLDERS’ DEFICIT"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/CommitmentsAndContingencies" xlink:title="00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/RelatedPartyTransactions" xlink:title="00000017 - Disclosure - RELATED PARTY TRANSACTIONS"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/SubsequentEvents" xlink:title="00000018 - Disclosure - SUBSEQUENT EVENTS"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/SummaryOfSignificantAccountingPoliciesAndOrganizationPolicies" xlink:title="00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (Policies)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/SummaryOfSignificantAccountingPoliciesAndOrganizationTables" xlink:title="00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/EquipmentTables" xlink:title="00000021 - Disclosure - EQUIPMENT (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/RightToUseAssetsAndLeaseLiabilityTables" xlink:title="00000022 - Disclosure - RIGHT TO USE ASSETS AND LEASE LIABILITY (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/ConvertibleNotesTables" xlink:title="00000023 - Disclosure - CONVERTIBLE NOTES (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/StockholdersDeficitTables" xlink:title="00000024 - Disclosure - STOCKHOLDERS’ DEFICIT (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/RelatedPartyTransactionsTables" xlink:title="00000025 - Disclosure - RELATED PARTY TRANSACTIONS (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/ScheduleOfAntidilutiveSecuritiesOfEarningsPerShareDetails" xlink:title="00000026 - Disclosure - SCHEDULE OF ANTIDILUTIVE SECURITIES OF EARNINGS PER SHARE (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/ScheduleOfAntidilutiveSecuritiesOfEarningsPerShareDetailsParenthetical" xlink:title="00000027 - Disclosure - SCHEDULE OF ANTIDILUTIVE SECURITIES OF EARNINGS PER SHARE (Details) (Parenthetical)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/ScheduleOfFairValueOfFinancialInstrumentsDetails" xlink:title="00000028 - Disclosure - SCHEDULE OF FAIR VALUE OF FINANCIAL INSTRUMENTS (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/ScheduleOfGoldInBullionDetails" xlink:title="00000029 - Disclosure - SCHEDULE OF GOLD IN BULLION (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/SummaryOfSignificantAccountingPoliciesAndOrganizationDetailsNarrative" xlink:title="00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/GoingConcernDetailsNarrative" xlink:title="00000031 - Disclosure - GOING CONCERN (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000032 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/EquipmentDetailsNarrative" xlink:title="00000033 - Disclosure - EQUIPMENT (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/ScheduleOfOperatingLeasesDetails" xlink:title="00000034 - Disclosure - SCHEDULE OF OPERATING LEASES (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/ScheduleOfMinimumLeasePaymentsDetails" xlink:title="00000035 - Disclosure - SCHEDULE OF MINIMUM LEASE PAYMENTS (Details)">

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>

<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" weight="1"/>

</link:calculationLink>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/RightToUseAssetsAndLeaseLiabilityDetailsNarrative" xlink:title="00000036 - Disclosure - RIGHT TO USE ASSETS AND LEASE LIABILITY (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/NotePayableRelatedPartyDetailsNarrative" xlink:title="00000037 - Disclosure - NOTE PAYABLE – RELATED PARTY (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/LoanPayableDetailsNarrative" xlink:title="00000038 - Disclosure - LOAN PAYABLE (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/ScheduleOfFairValueWarrantsDetails" xlink:title="00000039 - Disclosure - SCHEDULE OF FAIR VALUE WARRANTS (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/SummaryOfConvertibleDebtDetails" xlink:title="00000040 - Disclosure - SUMMARY OF CONVERTIBLE DEBT (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/ConvertibleNotesDetailsNarrative" xlink:title="00000041 - Disclosure - CONVERTIBLE NOTES (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/ScheduleOfOptionAssumptionDetails" xlink:title="00000042 - Disclosure - SCHEDULE OF OPTION ASSUMPTION (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/ScheduleOfWarrantsActivityDetails" xlink:title="00000043 - Disclosure - SCHEDULE OF WARRANTS ACTIVITY (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/ScheduleOfWarrantsOutstandingDetails" xlink:title="00000044 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/ScheduleOfOptionsActivityDetails" xlink:title="00000045 - Disclosure - SCHEDULE OF OPTIONS ACTIVITY (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/ScheduleOfOptionsOutstandingDetails" xlink:title="00000046 - Disclosure - SCHEDULE OF OPTIONS OUTSTANDING (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/StockholdersDeficitDetailsNarrative" xlink:title="00000047 - Disclosure - STOCKHOLDERS’ DEFICIT (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000048 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/ScheduleOfAccountsPayableAndAccruedExpensesRelatedPartyDetails" xlink:title="00000049 - Disclosure - SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES RELATED PARTY (Details)">

<link:loc xlink:type="locator" xlink:href="kblb-20230331.xsd#KBLB_AccountsPayableAndAccruedExpensesRelatedParty" xlink:label="loc_KBLBAccountsPayableAndAccruedExpensesRelatedParty"/>

<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableCurrentAndNoncurrent"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_KBLBAccountsPayableAndAccruedExpensesRelatedParty" xlink:to="loc_us-gaapAccountsPayableCurrentAndNoncurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="kblb-20230331.xsd#KBLB_AccruedExpensesRelatedParty" xlink:label="loc_KBLBAccruedExpensesRelatedParty"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_KBLBAccountsPayableAndAccruedExpensesRelatedParty" xlink:to="loc_KBLBAccruedExpensesRelatedParty" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="kblb-20230331.xsd#KBLB_AccruedInterestRelatedParty" xlink:label="loc_KBLBAccruedInterestRelatedParty"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_KBLBAccountsPayableAndAccruedExpensesRelatedParty" xlink:to="loc_KBLBAccruedInterestRelatedParty" xlink:type="arc" weight="1"/>

</link:calculationLink>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000050 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="00000051 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetailsParenthetical" xlink:title="00000052 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) (Parenthetical)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/ScheduleOfComponentsDeferredIncomeTaxesDetails" xlink:title="00000053 - Disclosure - SCHEDULE OF COMPONENTS DEFERRED INCOME TAXES (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://kraiglabs.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000054 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)"/>

</link:linkbase>

19 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/29/23  Kraig Biocraft Laboratories, Inc. 10-K       12/31/22   70:8.7M                                   M2 Compliance LLC/FA
 4/14/22  Kraig Biocraft Laboratories, Inc. S-1/A                 65:10M                                    M2 Compliance LLC/FA
 1/20/22  Kraig Biocraft Laboratories, Inc. 8-K:1,2,8,9 1/20/22   18:1.4M                                   M2 Compliance LLC/FA
 3/26/21  Kraig Biocraft Laboratories, Inc. 8-K:1,2,8,9 3/26/21   10:1.2M                                   M2 Compliance LLC/FA
 1/26/21  Kraig Biocraft Laboratories, Inc. 8-K:1,3,8,9 1/26/21    4:217K                                   M2 Compliance LLC/FA
12/11/20  Kraig Biocraft Laboratories, Inc. 8-K:1,2,8,912/11/20    5:541K                                   M2 Compliance LLC/FA
 6/02/20  Kraig Biocraft Laboratories, Inc. S-1                   71:7.9M                                   M2 Compliance LLC/FA
 3/27/20  Kraig Biocraft Laboratories, Inc. 10-K       12/31/19   62:4.6M                                   M2 Compliance LLC/FA
 3/31/15  Kraig Biocraft Laboratories, Inc. 10-K       12/31/14   50:4.1M                                   Issuer Direct/FA
 1/30/15  Kraig Biocraft Laboratories, Inc. S-1/A                  6:5.4M                                   Issuer Direct/FA
 1/21/15  Kraig Biocraft Laboratories, Inc. 8-K:5,7,9   1/20/15    3:98K                                    Issuer Direct/FA
12/19/13  Kraig Biocraft Laboratories, Inc. 8-K:3,5,9  12/17/13    2:901K                                   Issuer Direct/FA
11/22/13  Kraig Biocraft Laboratories, Inc. 8-K:5,9    11/15/13    2:678K                                   Issuer Direct/FA
 8/01/11  Kraig Biocraft Laboratories, Inc. S-1                    4:3.4M                                   EdgarAgents LLC/FA
 4/15/10  Kraig Biocraft Laboratories, Inc. 10-K       12/31/09    5:1.5M                                   EdgarAgents LLC/FA
 1/25/10  Kraig Biocraft Laboratories, Inc. S-1/A                  3:2.5M                                   EdgarAgents LLC/FA
10/02/09  Kraig Biocraft Laboratories, Inc. S-1                    4:2.3M                                   EdgarAgents LLC/FA
 3/26/08  Kraig Biocraft Laboratories, Inc. 10KSB      12/31/07    4:881K                                   EdgarAgents LLC/FA
 9/26/07  Kraig Biocraft Laboratories, Inc. SB-2                   9:1.7M                                   EdgarAgents LLC/FA

↑Top

Filing Submission 0001493152-23-020299 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Kraig Biocraft Laboratories, Inc. – ‘S-1/A’ on 6/6/23 – ‘EX-101.CAL’

On: Tuesday, 6/6/23, at 4:31pm ET · Accession #: 1493152-23-20299 · File #: 333-238883

Pre-Effective Amendment to Registration Statement (General Form) — Form S-1 — SA’33Filing Table of Contents

‘EX-101.CAL’ — XBRL Calculations — kblb-20230331_cal

This Exhibit is an XBRL File.

19 Previous Filings that this Filing References

Pre-Effective Amendment to Registration Statement (General Form) — Form S-1 — SA’33

Filing Table of Contents